Mateus de Oliveira Taveira (Mateus Taveira)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Contrast Enhanced

Positron Emission Tomography

Ejection Fraction

Top Venues

Molecular cancer research : MCR

Radiology. Imaging cancer

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Mateus de Oliveira Taveira, Milton José de Barros E Silva, Paula Nicole Vieira Pinto Barbosa
Imaging-calculated splenic volume is associated with response in melanoma patients treated with immunotherapy. Immunotherapy 15 (5) (2023)
Mateus de Oliveira Taveira, Milton José de Barros E Silva, Paula Nicole Vieira Pinto Barbosa
Imaging-calculated splenic volume is associated with response in melanoma patients treated with immunotherapy. Immunotherapy (2023)
Mateus de Oliveira Taveira, Milton José de Barros E Silva, Paula Nicole Vieira Pinto Barbosa
Imaging-calculated splenic volume is associated with response in melanoma patients treated with immunotherapy. Immunotherapy 15 (5) (2023)
Mateus de Oliveira Taveira
Comparison of 68Ga-FAPI versus 18F-FDG PET/CT for Initial Cancer Staging. Radiology. Imaging cancer 3 (2) (2021)
Sabrina Becker, Christina Kiecke, Eva Schäfer, Ursula Sinzig, Lena Deuper, Pablo Trigo-Mourino, Christian Griesinger, Raphael Koch, Zuzanna Rydzynska, Bjoern Chapuy, Frederike von Bonin, Dieter Kube, Vivek Venkataramani, Hanibal Bohnenberger, Andreas Leha, Johanna Flach, Sascha Dierks, Holger Bastians, Brigitte Maruschak, Kamil Bojarczuk, Mateus de Oliveira Taveira, Lorenz Trümper, Gerald Georg Wulf
Destruction of a Microtubule-Bound MYC Reservoir during Mitosis Contributes to Vincristine's Anticancer Activity. Molecular cancer research : MCR 18 (6) (2020)
Man-Li Luo, Fang Zheng, Wenying Chen, Zhi-Mei Liang, Gurushankar Chandramouly, Jianan Tan, Nicholas A Willis, Chun-Hau Chen, Mateus de Oliveira Taveira, Xiao Zhen Zhou, Kun Ping Lu, Ralph Scully, Gerburg M Wulf, Hai Hu
Inactivation of the Prolyl Isomerase Pin1 Sensitizes BRCA1-Proficient Breast Cancer to PARP Inhibition. Cancer research 80 (14) (2020)